Studying a new device for severe tricuspid valve leakage
Part of Heart & circulation clinical trials.
This trial tests a device called the Pivot Bridge System to treat severe leakage of the tricuspid valve (the valve between the right upper and lower heart chambers). The goal is to see if it safely reduces symptoms like swelling and shortness of breath.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been on water pills or other heart medications for your tricuspid valve leakage for at least 1 month
- Your tricuspid valve leakage is severe (grade 4+) on an ultrasound, and you have symptoms like fatigue or fluid buildup (NYHA class II or higher)
- Your right heart chamber is larger than your left on imaging tests
- Your tricuspid valve ring measures at least 40 mm on a CT scan
- A heart team (including a heart doctor and a heart surgeon) has said you need surgery for this valve problem
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new, less-invasive device to fix the tricuspid valve in the heart for people with severe leakage. It may be an option if you are not a good candidate for traditional open-heart surgery and have tried other treatments.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This early study tests a minimally invasive device that helps tighten (repair) the tricuspid valve ring to reduce severe leaking. It may help people who still have symptoms from right-sided heart failure even after taking the best available medicines.
This trial tests a new, less-invasive device called 'Pivot Extend' for people with a severe leaky tricuspid valve (tricuspid regurgitation) who still have symptoms despite taking medicines. The goal is to see if the device can safely help reduce the leak and improve symptoms.
This trial tests a new device (Pivot Extend) to fix a severe leak in your tricuspid heart valve. It is for people who still have symptoms like shortness of breath or fatigue despite taking medicine.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
Hear when a new Tricuspid Regurgitation Functional trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.